Загрузка...
High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
We systematically searched in PubMed, Web of Science, Embase and China National Knowledge Infrastructure from the inception to March 31, 2017, identified relevant trials about efficacy of high-does Atorvastatin for patients with percutaneous coronary intervention. Twelve studies with the number of 2...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642560/ https://ncbi.nlm.nih.gov/pubmed/29050285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19701 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|